Related Experiment Video
Updated: Sep 30, 2026
One-anastomosis Gastric Bypass (OAGB) in Rats
Published on: November 10, 2018
Laparoscopic adjustable gastric banding for the treatment of morbid obesity
James D Evans1, Michael H Scott, Annemarie S Brown
1Department of Surgery, Whiston Hospital, Merseyside, UK. jimevans@doctors.org.uk
Background:
This prospective study evaluated the effectiveness and safety of laparoscopic adjustable gastric banding (LAGB) for morbid obesity.
Methods:
Ninety-five consecutive patients (89 female; median age 38 years, range 19 to 69) underwent LAGB for morbid obesity. Median weight and body mass index were 123.2 (88.9 to 228.6) kg and 45 (32.7-76.4) kg/m(2) respectively. Significant coexistent disease was present in 52 (55%) patients.
Results:
Median excess weight loss was 53% (range 96.9% to 12.1%) and 62% (range 107.5% to 32.3%) at 1 and 2 years respectively (P <0.001). Median operative time was 90 (range 35 to 285) minutes and inpatient stay 2 (range 1 to 10) days. Early complications were seen in 17 (18%) patients most commonly nausea/vomiting or dysphagia. Late complications were seen in 25 (26.3%) patients, most frequently vomiting or reflux due to band slippage or pouch dilatation. There was 1 (1%) operative death.
Conclusions:
LAGB is an effective operation for morbid obesity that results in equivalent weight loss to open surgical procedures.
